Doyle Mittie - Insider Non-Derivative Transactions at Avalo Therapeutics, Inc. (AVTX) - (SEC)
Updated on March 12, 2026.
According to recent SEC insider information filed on Dec 10, 2025, Doyle Mittie's relationship to Avalo Therapeutics, Inc. (AVTX) is Officer (Chief Medical Officer), and currently has 3,622 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AVTX insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Doyle Mittie - Insider Non-Derivative Transactions at AVTX
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 11, 2025 | F -- (Common Stock) | 1013 | 4.1 | 3622 |